Oncology

Established in January 2000, the Pharmatech Oncology Research Network is the largest of the Pharmatech Research Networks. With more than 400 investigative sites representing almost 1400 community-based oncologists, our strength manifests in Network members’ successes in conducting clinical trials. Each physician’s participation adds to this strength, giving us a unique resource to offer to the pharmaceutical and biotech industries.

Pharmatech has worked extremely hard to establish relationships with pharmaceutical and biotechnological companies. Our experience in conducting trials involving chemotherapy applications, hematological indications, and supportive therapies for cancer patients gives physicians who work with us a cutting edge in running clinical research trials.

Clinical trials offer additional treatment options for patients during difficult times. Through the network of investigators in the Pharmatech Oncology Research Network, patients always come first; whether reviewing a study’s feasibility, supporting the integration of a research business model into a practice’s current operations, or helping Investigators better understand the specifics of a certain study protocol.

If you are looking to participate in clinical trials, we invite you to become a valuable member of the Pharmatech Oncology Research Network.  Please register for the Network or contact us to get more information.